Current CDC travel health notices show no Level 4 “Avoid All Travel” advisories active for any destination, with ongoing Ebola Bundibugyo responses in the Democratic Republic of the Congo and Uganda held at Level 3 and other alerts limited to Level 2 or below. Official monitoring through June 2026 indicates contained transmission and available precautions that have not triggered escalation criteria. This data, combined with the absence of novel extreme-risk pathogens or widespread unmitigable outbreaks since early-year updates, underpins trader consensus favoring no issuance by year-end. Markets will continue tracking CDC surveillance reports and any rapid deterioration in case trajectories or geographic spread that could meet Level 4 thresholds.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · ОбновленоCDC выпустит предупреждение 4-го уровня до 31 декабря?
Да
$71,851 Объем
$71,851 Объем
Да
$71,851 Объем
$71,851 Объем
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Открытие рынка: Jan 19, 2026, 3:15 PM ET
Resolver
0x65070BE91...A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Resolver
0x65070BE91...Current CDC travel health notices show no Level 4 “Avoid All Travel” advisories active for any destination, with ongoing Ebola Bundibugyo responses in the Democratic Republic of the Congo and Uganda held at Level 3 and other alerts limited to Level 2 or below. Official monitoring through June 2026 indicates contained transmission and available precautions that have not triggered escalation criteria. This data, combined with the absence of novel extreme-risk pathogens or widespread unmitigable outbreaks since early-year updates, underpins trader consensus favoring no issuance by year-end. Markets will continue tracking CDC surveillance reports and any rapid deterioration in case trajectories or geographic spread that could meet Level 4 thresholds.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · Обновлено
Не доверяй внешним ссылкам.
Не доверяй внешним ссылкам.
Часто задаваемые вопросы